CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX

CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX GlobeNewswire November 17, 2025 LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) violations of §§10(b) and […]

Winthrop Wealth Named to Inc.’s 2025 Best Workplaces List

Annual list recognizes the businesses that set the standard for workplace success and awards excellence in company culture Winthrop Wealth is thrilled to announce its inclusion onInc. magazine's 2025 Best Workplaces list, which honors companies that foster exceptional workplace cultures and prioritize the well-being of their employees. https://mma.prnewswire.com/media/2549537/WW_Logo.jpg The annual list, featured on Inc.com, recognizes

Honda Powers the Dreams of Team USA Athletes as They Go for Gold in Milano Cortina

— Meet Team Honda: 10 Team USA athletes serving as official Honda ambassadors for the Olympic andParalympic Winter Games Milano Cortina 2026 — Honda is the Official Automotive Partner of Team USA, supporting the United States Olympic andParalympic Teams during Milano Cortina 2026 and the LA28 Games Honda today announced the selection of 10 inspiring

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization

Anixa Biosciences, Inc.(“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) approved “liraltagene autoleucel” for the non-proprietary name of the Company's novel FSHR-targeted CAR-T therapy for recurrent ovarian cancer. The INN

Levi & Korsinsky Releases SueWallSt Podcast on James Hardie Industries plc. (JHX) Lawsuit

NEW YORK, NY / ACCESS Newswire / November 17, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding James Hardie Industries plc. (NYSE:JHX) class action securities lawsuit A Class Action lawsuit was filed on behalf of James Hardie Industries plc. investors who lost money as a result of alleged securities fraud between May 20,

Halda Therapeutics Announces Acquisition by Johnson & Johnson

Halda Therapeutics Announces Acquisition by Johnson & Johnson GlobeNewswire November 17, 2025 Halda to be acquired by Johnson & Johnson for $3.05 billion in cash Halda recently presented positive Phase 1/2 data for HLD-0915 in metastatic castration-resistant prostate cancer and continues rapid clinical development Additional RIPTAC(TM) programs in development for major solid tumor types and

VITASĀ® Healthcare Expands Hospice Care in Florida, Now Serving Pinellas County

More Florida residents can now choose VITAS Healthcare, the nation's leading provider of end-of-life care, for their hospice and palliative care needs. On Nov. 14, VITAS began accepting hospice-eligible patient referrals in Pinellas County, ensuring that residents in St. Petersburg, Clearwater, Tarpon Springsand surrounding communities have access to expert care close to home. VITAS Healthcare

Synack Introduces New Agentic AI Pentesting Solution

Agents Speed Up Test Results, Reduce Costs, and Scale Across the Attack Surface Synack, a pioneer in offensive security, today announced Sara Pentest, a new agentic AI product built on the Synack Autonomous Red Agent (Sara) architecture. Sara Pentest performs penetration testing on hosts and web applications, speeding up vulnerability detection and remediation and reducing

Inspire Advisors Named to Newsweek’s Top Financial Advisory Firms 2026

Inspire Advisors, a faith-based Registered Investment Advisor (RIA), was awarded a 5-star rating and named to the top 1,000 financial advisory firms in the U.S. by Newsweek and Plant-A Insights. Earlier this year, Inspire Advisors also ranked #3 in the nation by USA Today and Statista as a top financial advisory firm for 2025 based

MedStar Washington Hospital Center Surpasses 500th HeartMate 3 LVAD Implant, Leading the Nation in Cardiac Innovation

Lifesaving therapy offers hope for patients with advanced heart failure,serving as a bridge to heart transplantation or long-term therapy. MedStar Washington Hospital Center has reached a major milestone in cardiac care by completing more than 500 HeartMate 3 Left Ventricular Assist Device (LVAD) implantations. This cutting-edge mechanical heart pump provides lifesaving support for patients with

Scroll to Top